Navigation Links
New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
Date:2/25/2010

Huixin He, associate professor, nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, like bacteria, can develop resistance to drug therapy, leading to a relapse of the disease.

As reported in the December 21, 2009, issue of the journal Small, He, Minko and their co-researchers, including investigators from Merck & Co. and Carl Zeiss SMT, a global nanotechnology firm, have designed nanomaterials that allow for the targeted and simultaneous delivery of a chemical drug to destroy cancer cells and a genetic drug to prevent drug resistance.

"We modified the surface of mesoporous silica nanoparticles so that an anticancer drug, doxorubicin, could be loaded into the pores of the silica nanoparticles. Also loaded onto the nanoparticles was a genetic drug designed to prevent or remove multidrug resistance outside the nanoparticles," explained He.

When administered to multidrug-resistant ovarian cancer cells, the nanoparticle treatment was more than 130 times more lethal than when doxorubicin was administrated alone . Most importantly, "the drug can only be released when it is inside the cancer cells. This controlled internal release mechanism can dramatically eliminate side effects associated with anticancer drugs to normal tissues," He noted.

Battling Aggressive Breast Cancer with Nanotubes

In related research, Professor He and another team of co-researchers have developed single-walled carbon nanotubes, consisting of cylinders of carbon about a nanometer in length, that hold the potential of providing a more effective means for detecting and selectively destroying aggressive breast cancer cells.

In a paper published in BMC Cancer late last year, the researchers showed that by chemically bonding a special antibody onto the nanotubes and taking advantage of two unique optical properties of carbon nanotubes (strong Raman scattering and near infrared absorption), single cancer cells can be detected and selectively eradicated while leaving the nearby normal cells unharmed. A uniqueness of this approach is that it offers the advantage of being more easily extended to other types of cancer cells. He's research in the areas of cancer detection and treatment is funded in part with grants from the National Science Foundation and National Cancer Institute.

Research Focuses on Practical Applications Across a Wide Range of Fields

The application of He's nanotechnology research is far and wide. In other research, He and members of her lab at Rutgers are working on the practical application of nanomaterials as a molecular diagnostic tool for Parkinson's disease. Other research is focused on the development of a platform to detect the presence of chemical warfare agents for homeland defense. And in yet other research, He and her lab members are working on nanotechnology to precisely and selectively measure iron ions (Fe3+) in remote ocean atmosphere dust and sea water, which is critical for the study of greenhouse gases and climate change .

At Rutgers, He teaches an undergraduate course in analytical chemistry and graduate courses in electrochemical analytical chemistry and a new course she designed in scanning probe microscopy. She is the recipient of the 2009 Rutgers Presidential Fellowship for Teaching Excellence.


'/>"/>

Contact: Helen Paxton
paxton@andromeda.rutgers.edu
973-353-5262
Rutgers University
Source:Eurekalert

Related medicine news :

1. Hard to Treat Diseases (HTDS) Update On Various Business Developments Evaluations and Proposals
2. DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World
3. Recent Developments in Transplantation Headline AST Meeting
4. Thomson Reuters Launches New Developments to Support Synthetic Chemists
5. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
6. Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
7. Human Genome Sciences Announces Second-Quarter 2009 Financial Results and Key Developments
8. Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference Today, July 9, 2009; Company Will Discuss Recent Developments, New Partnerships and Initiatives for MedFlash EPHR, and Second Quarter Results
9. MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009
10. Latest Developments In Facelift Surgery - Expert Opinion by Mr James Murphy
11. iJET Provides Additional Services in Response to Ongoing H1N1 Influenza A (Swine Flu) Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being ... Block Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for ... of Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative ...
(Date:2/5/2016)... ... , ... After years as an active staff surgeon and having served as ... Wayne Carman transitioned to chief of the Division of Plastic Surgery at what is ... chief and began a second three-year term in January of 2016. , The original ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know ... having to wait longer to access the treadmills. It’s a predictable trend. After the ... lose weight and get in shape by joining gyms, starting new walking or running ...
(Date:2/5/2016)... Georgia (PRWEB) , ... February 05, 2016 , ... Dr. ... to announce their 2nd Annual No Cost Dental Day to individuals in need. The ... The purpose of this No Cost Dental Day is to provide dental care to ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that should ... event they are experiencing an illness. Migraines are a severe form of a headache ... migraines would not wish the pain on their worst enemy, the feeling can last ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  Aralez Pharmaceuticals Inc. ... of POZEN Inc. ("POZEN") and Tribute Pharmaceuticals Canada Inc. ("Tribute") ... and shareholders of Tribute. The combined company will operate ... company with operations in Canada , ... United States . Under the terms of the ...
(Date:2/5/2016)... February 5, 2016 --> ... report states that the global active pharmaceuticals ingredients (APIs) ... predicted to reach US$185.9 bn by 2020. It is ... 2014 to 2020. The title of the report is ... by Geography, and by Therapeutic Area) - Global Industry ...
(Date:2/5/2016)... Feb. 5, 2016  Henry Schein, Inc. (NASDAQ: HSIC ... and services to office-based dental, animal health and medical ... agreement to acquire a majority ownership interest in Dental ... in Brazil . ... Dental Cremer is the dental distribution business of Cremer ...
Breaking Medicine Technology: